Yellow Fever Resources for Health Care Providers
Yellow Fever Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5117a1.htm
The 2002 recommendations include new or updated information regarding 1) reports of yellow fever vaccine-associated viscerotropic disease (previously reported as febrile multiple organ system failure); 2) use of yellow fever vaccine for pregnant women and persons infected with human immunodeficiency virus (HIV); and 3) concurrent use of yellow fever vaccine with other vaccines.
Information on Travelers’ Health (Yellow Book)
http://wwwn.cdc.gov/travel/yellowBookCh4-YellowFever.aspx
This site includes information on risks for travelers, contraindications for vaccination, adverse events following vaccination, international certificate of vaccination for yellow fever, and more.
Reporting Adverse Events Following Vaccination
http://vaers.hhs.gov/
Special Testing for Selected Patients with Severe Adverse Events Potentially Related to Yellow Fever Vaccination
http://wwwdev.cdc.gov/ncidod/dvbid/YellowFever/vaccine/special-testing.htm
How to Become Certified to Administer Yellow Fever Vaccine
http://wwwn.cdc.gov/travel/contentYellowFeverRegistryFAQ.aspx
Yellow Fever in Morbidity and Mortality Weekly Reports:
- Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep. 2002;51(RR-17):1-11.
- Adverse Events Associated with 17D-Derived Yellow Fever Vaccination --- United States, 2001--2002. 2002. Vol 51, No MM44;989.
- Fever, Jaundice, and Multiple Organ System Failure Associated With 17D-Derived Yellow Fever Vaccination, 1996—2001. MMWR 2001;50:343-5.
Yellow Fever in Select Publications:
Hayes EB. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg. 2007 Oct;101(10):967-71.
McMahon AW, Eidex RB, Marfin AA, et. al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases, Vaccine. 2007:25:1727-34.
Monath TP. Yellow fever vaccine. In: S. Plotkin, W. Orenstein and P.A. Offit, Editors, Vaccines (4th ed.), Saunders, Philadelphia. 2004. 1095–1176.
Chan RC, Penney DJ, Little D, et al. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001;358:121-2.
Martin M, Tsai TF, Cropp B, Chang GJ, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 2001;358:98-104.
Vasconcelos PF, Luna EJ, Galler R, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001;358:91-7.
Centers for Disease Control and Prevention. Notice to readers: Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996–2001. MMWR 2001;50:343-5.
Vellozzi C, Mitchell T, Miller E, Casey CG, Eidex RB, Hayes EB. Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004.Am J Trop Med Hyg 2006;75(2):333-6.
Huhn GD, Brown J,Perea W,Berthe A,Otero H,LiBeau G, Maksha N,Sankoh M, Montgomery S, Marfin A, Admassu M. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004. Vaccine 2006; 24(6):730-7.
Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 2005;5(2):137-45.
Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am. 2005 Mar;19(1):151-68, ix. Review.
Chang GJ, Kuno G, Purdy DE, Davis BS. Recent advancement in flavivirus vaccine development. Expert Rev Vaccines. 2004 Apr;3(2):199-220. Review.
Heymann DL. Control of Communicable Diseases Manual, 18th edition. Washington, DC: American Public Health Association, 2004.
Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002;33(4):330-42. Review.
Gubler DJ. Yellow fever. IN: Feigin RD and Cherry JD (eds.) Textbook of Pediatric Infectious Diseases, 4th ed., Philadelphia, PA: W.B. Saunders, 1998:1981-84.
Content Source:
Division of Vector Borne Infectious Diseases
National Center for Zoonotic, Vector-Borne, and Enteric Diseases